OS

O. James Sterling

Chief Financial Officer at Genetix Biotherapeutics Inc.

New York, US

About

O. James Sterling is the current Chief Financial Officer of Bluebird Bio. He previously worked at Renwick Capital as a Partner. O. James Sterling attended Columbia Business School.

Position in the VCSift Database

  • 288 investors hold the Chief Financial Officer role in VCSift. O. James Sterling is one of them.
  • 10,621 investors are based in New York, New York, United States.

Data sourced from 410,343 investor profiles. Updated July 2026.

Investment Focus

Contact Information

em••••@example.com
linkedin.com/in/••••••••

Unlock contact details with a VCSift subscription

Unlock Contact

Already subscribed? Log in

Find more investors like O. James

Search Investors